Remove 2022 Remove Medical Records Remove Pharmaceutical Companies
article thumbnail

Pharma Marketing Solutions That Help Address Whitespace

PharmaKinnex

Pharma Marketing Solutions That Help Address Whitespace April 13, 2022. Whitespace in pharma marketing refers are areas where pharma companies don’t add a field salesforce presence in because of the lack of ROI caused by smaller population size and lower sales potential for each physician. Inside Sales – Unlimited Possibilities.

article thumbnail

Success Guidelines For Pharma Contract Inside Sales Forces

PharmaKinnex

Success Guidelines For Pharma Contract Inside Sales Forces April 18, 2022. Inside sales teams supply services, such as research, digital marketing, direct mail campaigns, electronic medical record marketing & advertising, etc. The benefits of which provide pharma companies with flexibility and scalability.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

As Apple Rolls Out Medication Tracking to all iPhones, Pharma Must Embrace Connectivity

pharmaphorum

You wave your iPhone over a digital kiosk, instantly uploading your current medical record and insurance information. As of August 2022, the iPhone boasts more than 2.18 can be classified as “medical.” We take Apple Health here.” Your co-pay is then deducted from a Health Savings Account. The doctor will see you now.

article thumbnail

Budget expectation: Bring GST rate on APIs at par with the formulations

Express Pharma

In the Union Budget 2022-23, the Ministry of Health and Family Welfare received an allocation of about Rs 86,200 crore, representing a 16.5 These companies do not avail of any specified incentive or deductions; they may opt to pay tax at a concessional rate of 15 per cent. – 18 of 2022 (Question No.

article thumbnail

Unlocking disease treatment with large-scale research

pharmaphorum

The research programme was officially launched at the end of October 2022, and has the aim of building a resource of five million individuals’ information by 2025. It is also on target to raise additional funds of approximately £160 million from disease-related charities and from companies working within the life sciences industry.